ANALYLITICS | Cannabis Brokers

Arizona

ANALYTICS

In September 2019, cannabis sales in Arizona’s medical dispensaries were $61.4 million, a three percent decrease from August, attributable to seasonal declines at the end of summer as well as likely fallout from the scare in the vape segment. Compared to the previous September, sales in Arizona increased over 35 percent. Year-to-date through September, sales have reached $519.2 million, an $80.2 million increase from the same period last year.

Flower sales accounted for nearly 49 percent of overall revenue for the month with $30 million in sales. Pre-rolled joints, which are tracked as a separate category, accounted for more than three percent of revenue with $2.1 million in sales. Compared to the previous September, Flower sales increased by 54 percent and Pre-rolled joints increased by 28 percent.

Concentrate sales accounted for 35 percent of overall revenues with sales totaling $21.5 million in September. Vape products, the largest segment of the Concentrates category, generated $14.1 million in sales, accounting for 65 percent of the Arizona Concentrates market and 23 percent of sales across all categories. Compared to September 2018, sales of Dabbable Concentrates grew 23 percent, while Vape sales grew by 21 percent.

Ingestibles are a new classification that includes both Edibles and Sublinguals while also distinguishing the two subcategories. The Ingestibles category accounted for 11 percent of sales in September with $6.6 million in revenue. In September, sales from Edibles generated more than 87 percent of Ingestibles sales overall; Sublinguals made up the remaining 13 percent. Compared to the previous September, Edibles sales increased by 24 percent and Sublingual sales increased eight percent.

Medical dispensary sales revenue and change from prior month (August 2019) and year (September 2018):

September 2019 Sales Growth from August 2019 Growth from September

Flower:$30M 2%54%

Pre-Rolls:$2.1M9%28%

Concentrates:$21.5M-9%22%

• Live Resin:$859K 1%42%

• Shatter:$2.8M-6%-2%

• Vape:$14.1M-12%21%

• Wax:$2.5M-1%71%

Ingestibles:$6.6M-4%22%

• Beverages:$222K5%-8%

• Candy:$3.4M-4%38%

• Chocolates:$584K10%29%

• Infused Foods:$1.2M-5%-3%

• Pills:$359K1%42%

• Tinctures:$809K-13%10%

Topicals:$464K-6%12%

Colorado

September sales in Colorado’s adult-use and medical dispensaries reached a combined $156.6 million, an 11 percent decrease from August, attributable to seasonal declines at the end of summer as well as likely fallout from the scare in the vape segment. Compared to the previous September, sales increased 14 percent. Adult-use retailers experienced a 16 percent sales increase from September 2018 while medical sales increased two percent.

In September, Flower sales accounted for 44 percent of all revenues, totaling $68.8 million. Flower decreased six percent from the trailing month but increased 14 percent from the previous September. Pre-rolled joints, which are tracked separately from Flower, generated $10 million in sales for September 2019, a 33 percent increase from September 2018.

Concentrate sales in September 2019 increased eleven percent from the previous year. With $48.7 million in sales coming from Concentrates, the category accounted for 31 percent of revenue for the month. Vape products, the largest segment within the Concentrates category, sold $25.3 million in September 2019, a 20 percent increase from September 2018.

Ingestibles are a new classification that includes both Edibles and Sublinguals while also distinguishing the two subcategories. In September 2019, sales from Ingestibles generated $24.2 million in sales, a 15 percent increase from September 2018. Compared to the trailing month, however, sales in the category decreased by nearly 10 percent.

Retail sales revenue and rate change from prior month (August 2019) and year (September 2018) for adult-use and medical channels combined are summarized below:

September 2019 Sales Growth from August 2019 Growth from September 2018

Flower:$68.8M-6%14%

Pre-Rolls:$10M-8%33%

Concentrates:$48.7M-17%11%

• Live Resin:$5.6M-7%-5%

• Rosin:$2M-15%103%

• Shatter:$4.8M-12%-6%

• Vape:$25.3M-23%20%

• Wax:$7.3M-6%14%

Ingestibles:$24.2M-10%15%

• Beverages:$1.7M-12%10%

• Candy:$14.1M-10%26%

• Chocolates:$3.6M-12%2%

• Infused Foods:$1.2M-2%-3%

• Pills:$1.2M-8%-15%

• Tinctures:$1.7M-12%-12%

Topicals:$2.6M-11%6%

Nevada

September 2019 Overview:

In September, Nevada dispensaries generated $56.9 million in sales. Compared to September of 2018, sales grew by 16 percent. Compared to the trailing month, sales decreased by 9 percent, attributable to seasonal declines at the end of summer as well as likely fallout from the scare in the vape segment.

Flower sales accounted for almost 44 percent of overall sales in September. Sales in the category reached $25 million for the month, a four percent decrease from August. Pre-rolled joints, a category tracked separately from Flower, accounted for nearly 15 percent of September sales with more than $8.5 million in revenue.

Concentrate sales for the month reached $13.2 million, accounting for 23 percent of overall revenue. Compared to the previous September, category sales increased by six percent.

Ingestibles are a new classification that includes both Edibles and Sublinguals while also distinguishing the two subcategories. Sales in the Ingestibles category accounted for 15 percent of all revenues with $8.3 million in sales for the month of September. Compared to August, category sales decreased by eight percent.

Retail sales revenue, rate of change from prior month (August 2019) and year over-year comparisons within Nevada’s adult-use and medical channels (combined) are summarized below:

September 2019 Sales Growth from August 2019 Growth from September 2018

Flower:$25M-4%29%

Pre-Rolls:$8.5M-4%16%

Concentrates:$13.2M-20%6%

• Live Resin:$931K-8%53%

• Rosin:$17K53%-53%

• Shatter:$371K-25%-32%

• Vape:$10.4M-21%7%

• Wax:$751K-22%33%

Ingestibles:$8.3M-8%4%

• Beverages:$418K-21%-24%

• Candy:$4.6M-5%19%